The data presented herein indicate that β-arrestin2 expression gradually decreases with increasing HCC cell line metastatic potential, and that β-arrestin2 overexpression inhibits HCC cell metastasis and invasion, reduces Akt activation, increases E-cadherin expression, and decreases vimentin expression. Here, CDH1 is linked to hepatocellular carcinoma.